The Dental Sleep Medicine Market a new research report released by MarketResearchFuture.com report analyzes the Global Market 2018 economy status and prediction categorizes the Dental Sleep Medicine Market size and share by leading players, product types, application, and Dental Sleep Medicine Market classification by top key regions.
Pune, India -- (SBWIRE) -- 12/13/2018 -- Key Players
Market Research Future (MRFR) recognizes the following companies as the key players in Dental Sleep Medicine Market: There are plenty of large and small market players which operate in this market all over the globe.
There are various market players operating in the global Dental sleep medicine market. Some of the key market players in this market are: BMC Medical Co., Ltd., GE Healthcare, Braebon Medical Corporation, Cadwell Laboratories Inc., CareFusion Corp, Compumedics Limited, Curative Medical Inc., Fisher & Paykel Healthcare, Invacare Corporation, Philips Healthcare and Teleflex, Inc.
Founded on 1989, headquartered at San Diego, US. ResMed, is engaged in the manufacturing and distribution of medical devices to diagnose, treat and manage various respiratory disorders. The firm also offers cloud-based software informatics solutions to manage patient results. The firm has its presence all over the world with distribution network in over 120 countries. The company has focused on various inorganic and organic growth strategies to enhance its product portfolio and gain foothold in various geographies. For instance in the year 2016, ResMed launched two products, AirFit N20 and AirFit F20 nasal masks. These nasal masks helps in positive airway pressure (PAP) treatment of sleep apnea. Additionally in 2016, ResMed acquired Maribo Medico, a firm engaged in the education, diagnosis and treatment of sleep disordered breathing problems. These strategies aims to increase the firm's customer base and enhance its geographic presence.
To Get Sample Report visit https://www.marketresearchfuture.com/sample_request/3021
Philips Healthcare offers healthcare solutions for treatment and diagnosis of sleep and respiratory related disorders. The firm offers products for airway management, anaesthesia, critical care, and oxygen & aerosol therapy. End users for this products include hospitals and home care. The firm has focused on various growth strategies such as expansions, product launches, acquisition and collaboration to enhance its product portfolio and widen its foothold in various geographies. For instance in 2015, Philips Respironics introduced Sleep Apnea Therapy System. This system includes a mask that will allow patient to comfortably sleep and a DreamStation that will help the patient to share his or her data with the physician. This product launch adds into the already extensive range of breathing systems that the firm offers.
Global Dental Sleep Medicine Market - Overview
Dental sleep medicine is one of the crucial segment of dentistry where the dentists are primarily focused on treating sleep-disordered breathing with the use of oral appliance therapy. Sleep-disorders include snoring and obstructive sleep apnea (OSA).Obstructive sleep apnea is caused due to excess weight, narrowed airway, hypertension, smoking, diabetes, family history, asthma. An oral appliance therapy includes the usage of device worn in the mouth only during sleep.
Global dental sleep medicine market is going to witness a healthy growth due to various factors. Factors such as rising prevalence of lifestyle induced diseases like obesity and cardiovascular diseases, adoption of innovative technologies and growing geriatric mass is likely to propel the growth of dental sleep medicine market. American academy of dental sleep medicine estimated that around 30 million adults in the U.S. have obstructive sleep apnea (OSA).
According to a recent survey, it was estimated that over 20 million adults in the U.S. suffer from obstructive sleep apnea and nearly 80% of them go untreated. Adult men over the age of 40 and people who are obese are at greater risk for acquiring obstructive sleep apnea.
Additionally, growing healthcare expenditure and infrastructure in many developing countries, and rising technological advancement for the diagnosis and treatment of various ailments remain a driving force for dental sleep market. For instance, US census Bureau, has estimated the older population to reach 1.6 billion from 2025 to 2050.
The restraints that are likely to hamper the growth of dental sleep medicine market are high treatment costs and lack of patient awareness.
The global dental sleep medicine market is segmented on the basis of treatment, diagnostics and end user. Treatment segment is sub-segmented into positive airway pressure (PAP) therapy, oral and nasal devices, airway systems, drugs, surgery, and other devices. Diagnostics segment is segmented into polysomnography and respiratory polygraphy, home oximetry and actigraph. On the basis of end user, the dental sleep medicine market is segmented into hospitals, sleep laboratories, and home.
Geographically, Dental sleep medicine market is segmented into four key regions: America, Europe, Asia Pacific, and Middle East & Africa. America is further segmented into North America and South America. And North America is segmented into US and Canada. Globally, US is the largest market for dental sleep medicine owing to increasing life style diseases such as obesity and cardiovascular disorders. Growing geriatric population is likely to propel the growth of dental sleep market. Population Reference Bureau has estimated that aging population in America is expected to reach 98 million by 2060 from 46 million in 2016. Additionally according to CDC, in 2017, around 36.5% adults in US are obese. Similarly increasing healthcare spending is likely to grow the demand for dental sleep medicine market. Europe accounts for the second largest market share due to increasing government support, focus of industry players, and introduction of innovative products. Asia pacific region is expected to be fastest growing region in dental sleep medicine market owing to its huge patient pool, increasing healthcare expenditure and demand for new treatment options. For instance, US Census Bureau has estimated that by 2050, two third of the world's older population will reside in Asia.
On the other hand, the Middle East & Africa is expected to witness limited growth due to limited access to the healthcare resources and lack of awareness about rare diseases. In the Middle East, the growth of the market is driven by increasing availability new diagnostic and treatment methods.
To Browse Complete Report visit https://www.marketresearchfuture.com/reports/dental-sleep-medicine-market-3021
Some Brief Table of Contents of Report
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope Of The Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
Do You Have Specific Requirement? Ask To Our Experts https://www.marketresearchfuture.com/enquiry/3021
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.